Complete Filing Data
MediWound Ltd. reported Cash And Cash Equivalents of $4.80 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean MediWound Ltd. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling General And Administrative Expense | $8.4M | $8.2M | $6.8M | $6.9M | $6.3M | $5.5M | $5.2M | $3.8M | $3.8M | $4.1M | $4.0M |
| Sales And Marketing Expense | $5.8M | $4.9M | $4.8M | $3.7M | $3.4M | $3.2M | $4.1M | $4.2M | $5.4M | $8.4M | $9.3M |
| Research And Development Expense | $14.3M | $8.9M | $7.5M | $10.2M | $10.3M | $7.7M | $5.0M | $4.1M | $5.5M | $7.1M | $6.0M |
| Profit Loss From Operating Activities | -$25.3M | -$19.4M | -$15.3M | -$8.3M | -$11.2M | -$8.8M | $4.5M | -$4.0M | -$13.7M | -$20.2M | -$21.2M |
| Profit Loss | -$23.9M | -$30.2M | -$6.7M | -$19.6M | -$13.6M | -$9.2M | $5.0M | -$1.1M | -$22.1M | -$18.9M | -$22.1M |
| Gross Profit | $3.3M | $2.6M | $3.6M | $13.2M | $8.8M | $7.5M | $19.9M | $1.3M | $918.0K | -$600.0K | -$1.9M |
| Cost Of Sales | $13.7M | $17.6M | $15.1M | $13.3M | $15.0M | $14.2M | $11.8M | $2.1M | $1.6M | $2.2M | $2.5M |
| Comprehensive Income | -$23.9M | -$30.2M | -$6.7M | -$19.6M | -$13.5M | -$9.2M | $5.0M | -$1.0M | -$22.2M | -$18.9M | -$22.1M |
| Adjustments For Reconcile Profit Loss | $3.0M | $15.3M | -$6.1M | $15.0M | $4.5M | $2.6M | $441.0K | -$10.1M | $9.7M | $458.0K | $2.2M |
| Adjustments For Increase Decrease In Other Payables And Deferred Revenue | -$1.1M | $517.0K | -$928.0K | $281.0K | -$2.0M | -$479.0K | $247.0K | -$161.0K | -$70.0K | -$1.0M | $1.3M |
| Revenue From Sale Of Goods | $5.8M | $6.8M | $6.3M | $5.3M | $9.6M | $7.4M | $3.4M | $3.4M | $2.4M | ||
| Revenue From Rendering Of Services | $10.8M | $13.1M | $12.3M | $12.9M | $12.4M | $13.9M | $10.7M | ||||
| Other Adjustments To Reconcile Profit Loss | $0.00 | $770.0K | $468.0K | $533.0K | $590.0K | -$433.0K | $1.7M | $758.0K | $351.0K | -$1.6M | -$764.0K |
| Other Comprehensive Income | -$21.0K | $7.0K | -$13.0K | $14.0K | $21.0K | -$23.0K | $8.0K | $13.0K | -$29.0K | $7.0K | $2.0K |
| Profit Loss From Continuing Operations | -$19.6M | -$13.6M | -$9.3M | $2.1M | -$5.7M | -$14.5M | -$18.9M | -$21.7M | |||
| Profit Loss Before Tax | -$23.7M | -$30.2M | -$6.5M | -$19.5M | -$13.5M | -$9.3M | $2.1M | ||||
| Income Tax Expense Continuing Operations | $169.0K | $61.0K | $185.0K | $78.0K | $27.0K | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $4.8M | $9.2M | $11.9M | $33.9M | $11.0M | $17.4M | $7.2M | $6.7M | $36.1M | $28.9M | $42.5M | $25.4M |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $5.5M | $6.3M | $6.5M | $555.0K | $489.0K | $923.0K | $792.0K | $522.0K | $1.0M | $671.0K | $376.0K | |
| Cash Flows From Used In Operating Activities | -$16.1M | -$13.6M | -$10.5M | -$11.9M | -$8.9M | -$6.9M | $8.3M | -$12.2M | -$16.5M | -$16.4M | -$19.6M | |
| Cash Flows From Used In Decrease Increase In Shortterm Deposits And Investments | -$14.0M | -$4.4M | -$29.8M | $0.00 | $4.0M | $18.0M | -$5.1M | -$16.6M | $1.2M | $2.1M | $36.2M | |
| Adjustments For Increase Decrease In Trade Account Payable | $2.4M | $406.0K | -$594.0K | $414.0K | $1.7M | -$1.1M | $1.4M | -$536.0K | -$135.0K | $2.2M | $33.0K | |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | $31.0K | -$30.0K | $83.0K | $109.0K | $13.0K | $33.0K | -$105.0K | $19.0K | $111.0K | $125.0K | $90.0K | |
| Adjustments For Decrease Increase In Trade Account Receivable | $3.2M | -$1.1M | $5.7M | -$7.6M | $929.0K | $1.4M | -$3.6M | -$211.0K | $28.0K | -$107.0K | -$181.0K | |
| Adjustments For Decrease Increase In Other Operating Receivables | $1.7M | $120.0K | -$894.0K | $364.0K | -$763.0K | -$13.0K | $6.4M | -$306.0K | -$1.2M | $33.0K | -$556.0K | |
| Adjustments For Changes In Increase Decrease In Asset And Liability Items | $4.8M | $1.3M | $2.3M | -$7.2M | $162.0K | -$61.0K | $4.5M | -$1.0M | -$2.4M | $2.0M | $275.0K | |
| Revaluation Of Liabilities In Respect Of Grants | $132.0K | -$919.0K | -$828.0K | $392.0K | -$287.0K | -$229.0K | $1.3M | $474.0K | ||||
| Cash Flows From Used In Financing Activities | $29.6M | $19.4M | $22.9M | $35.8M | -$1.1M | $46.0K | $23.0M | $907.0K | $778.0K | |||
| Cash Flows From Used In Investing Activities | -$18.0M | -$8.4M | -$34.3M | -$481.0K | $3.5M | $17.4M | -$6.9M | -$17.0M | $437.0K | $1.8M | $36.0M | |
| Retained Earnings | -$228.9M | -$205.0M | -$174.8M | -$168.1M | -$148.5M | -$135.0M | -$125.8M | -$130.7M | -$129.4M | -$107.3M | ||
| Property Plant And Equipment | $18.6M | $14.1M | $9.2M | $2.4M | $2.5M | $2.6M | $2.3M | $2.0M | $1.9M | $1.3M | ||
| Other Current Receivables | $1.1M | $1.5M | $1.4M | $650.0K | $927.0K | $462.0K | $450.0K | $6.8M | $3.2M | $2.4M | ||
| Other Current Payables | $4.5M | $3.6M | $3.9M | $4.2M | $3.6M | $2.9M | $5.7M | $2.0M | $2.2M | $2.1M | ||
| Noncurrent Recognised Liabilities Defined Benefit Plan | $472.0K | $404.0K | $456.0K | $360.0K | $288.0K | $292.0K | $243.0K | $348.0K | $330.0K | $219.0K | ||
| Noncurrent Liabilities | $16.9M | $15.8M | $16.7M | $27.0M | $13.6M | $15.5M | $15.0M | $21.4M | $29.1M | $22.6M | ||
| Noncurrent Assets | $26.3M | $21.3M | $16.8M | $4.2M | $4.8M | $4.9M | $5.0M | $2.6M | $2.6M | $2.2M | ||
| Intangible Assets Other Than Goodwill | $33.0K | $99.0K | $165.0K | $231.0K | $297.0K | $363.0K | $429.0K | $495.0K | $635.0K | $773.0K | ||
| Equity And Liabilities | $86.3M | $73.5M | $66.5M | $50.0M | $19.7M | $31.1M | $40.6M | $35.3M | $44.1M | $35.8M | ||
| Current Trade Receivables | $1.6M | $4.8M | $3.7M | $9.3M | $1.8M | $2.8M | $4.1M | $560.0K | $369.0K | $332.0K | ||
| Current Liabilities | $25.7M | $26.5M | $18.1M | $12.1M | $10.7M | $8.3M | $10.4M | $4.9M | $5.4M | $5.4M | ||
| Current Assets | $60.0M | $52.2M | $49.7M | $45.8M | $15.0M | $26.2M | $35.6M | $32.7M | $41.5M | $33.6M | ||
| Assets | $86.3M | $73.5M | $66.5M | $50.0M | $19.7M | $31.1M | $40.6M | $35.3M | $44.1M | $35.8M | ||
| Other Noncurrent Liabilities | $0.00 | $2.3M | $2.8M | $3.9M | $5.0M | $4.9M | $6.3M | $14.4M | $14.5M | |||
| Cash Flows From Used In Investing Activities Continuing Operations | $3.5M | $17.4M | -$5.7M | -$17.0M | $437.0K | |||||||
| Cash Flows From Used In Operating Activities Continuing Operations | -$11.9M | -$8.9M | -$6.7M | $9.9M | -$12.2M | -$14.9M | -$16.4M | -$19.6M | ||||
| Rightofuse Assets Increase Decrease In Revaluation Surplus | $1.4M | $480.0K | $6.8M | $117.0K | $155.0K | $261.0K | $209.0K | |||||
| Trade And Other Current Payables To Trade Suppliers | $5.5M | $5.7M | $4.7M | $3.0M | $4.1M | $2.7M | $3.3M | $3.3M | ||||
| Revaluation Of Lease Liabilities | $109.0K | -$188.0K | -$305.0K | -$340.0K | ||||||||
| Rightofuse Assets | $7.2M | $6.7M | $6.7M | $1.2M | $1.5M | $1.9M | $2.2M | |||||
| Shortterm Deposits Classified As Cash Equivalents | $48.3M | $34.0M | $29.8M | $0.00 | $0.00 | $4.0M | $22.0M | $16.8M | $1.2M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Cash And Cash Equivalents | -$4.4M | -$2.7M | -$22.0M | $22.8M | -$6.3M | $10.3M | $3.4M | -$29.4M | $8.8M | -$13.6M | $17.1M |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | $95.0K | -$84.0K | -$160.0K | -$549.0K | $88.0K | $273.0K | $140.0K | -$205.0K | $226.0K | $86.0K | -$143.0K |
| Payments Of Lease Liabilities Classified As Financing Activities | $1.2M | $928.0K | $778.0K | $701.0K | $693.0K | $508.0K | $630.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Par Value Per Share | $0.07 | $0.07 | $0.07 | $0.07 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | |
| Number Of Shares Issued | 12.8M | 10.8M | 9.2M | 7.2M | 3.9M | 27.2M | 27.2M | 27.2M | 27.0M | 21.9M | |
| Number Of Shares Outstanding | 12.8M | 10.8M | 9.2M | 7.2M | 3.9M | 27.2M | 27.2M | 27.2M | 27.0M | 21.9M | |
| Basic And Diluted Earnings Loss Per Share | $-0.34 | $0.18 | $-0.04 | $-0.95 | $-0.86 | $-1.02 | |||||
| Weighted Average Shares | 11.4M | 10.0M | 9.0M | 5.0M | 3.9M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Expense | $28.5M | $22.0M | $18.9M | $21.5M | $20.0M | $16.4M | $15.4M | $5.3M | $14.6M | $19.6M | $19.3M |
| Interest Received Classified As Investing Activities | $1.6M | $2.3M | $1.9M | $74.0K | $35.0K | $274.0K | $184.0K | $106.0K | $349.0K | $407.0K | $287.0K |
| Increase Decrease Through Sharebased Payment Transactions | $3.1M | $3.1M | $1.9M | $1.9M | $1.7M | $1.3M | $1.2M | $645.0K | $1.4M | $3.2M | $2.7M |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | $51.0K | -$47.0K | -$189.0K | -$525.0K | $137.0K | $211.0K | $152.0K | -$182.0K | $185.0K | $94.0K | -$69.0K |
| Finance Income | $4.0M | $2.0M | $10.7M | $461.0K | $11.0K | $843.0K | $556.0K | $412.0K | $406.0K | $2.2M | $1.1M |
| Finance Costs | $2.5M | $12.8M | $1.9M | $11.6M | $2.3M | $1.3M | $3.0M | $2.1M | $1.3M | $896.0K | $1.5M |
| Adjustments For Sharebased Payments | $3.1M | $3.1M | $1.9M | $1.9M | $1.7M | $1.3M | $1.2M | $645.0K | $1.4M | $3.2M | $2.7M |
| Adjustments For Finance Income Cost | $1.9M | $2.0M | $2.2M | $74.0K | $11.0K | $297.0K | $434.0K | $412.0K | $349.0K | $414.0K | $288.0K |
| Adjustments For Depreciation And Amortisation Expense | $1.9M | $1.5M | $1.3M | $1.3M | $1.2M | $1.1M | $1.1M | $577.0K | $567.0K | $589.0K | $503.0K |
| Adjustments For Decrease Increase In Inventories | -$1.4M | $187.0K | -$906.0K | -$721.0K | $257.0K | $141.0K | $67.0K | $206.0K | -$1.0M | $873.0K | -$273.0K |
| Reclassification Adjustments On Change In Value Of Foreign Currency Basis Spreads Net Of Tax | $21.0K | -$7.0K | $13.0K | -$14.0K | -$21.0K | $23.0K | -$8.0K | -$13.0K | $29.0K | -$7.0K | -$2.0K |
| Licence Fee Income | $390.0K | $255.0K | $160.0K | $8.2M | $1.8M | $383.0K | $17.7M | $176.0K | $118.0K | ||
| Number Of Shares Authorised | 20.0M | 20.0M | 20.0M | 12.9M | 7.1M | 50.0M | 50.0M | 37.2M | 32.2M | 32.2M | |
| Share Premium | $272.3M | $236.0M | $206.3M | $178.9M | $143.9M | $142.2M | $140.9M | $139.6M | $139.0M | $115.0M | |
| Reserve Of Change In Value Of Foreign Currency Basis Spreads | -$32.0K | -$11.0K | -$18.0K | -$5.0K | -$19.0K | -$40.0K | -$17.0K | -$25.0K | -$38.0K | -$9.0K | |
| Noncurrent Government Grants | $8.3M | $8.1M | $7.7M | $7.4M | $7.9M | $7.3M | $6.8M | $7.6M | $7.4M | $6.8M | |
| Issued Capital | $258.0K | $215.0K | $184.0K | $143.0K | $75.0K | $75.0K | $75.0K | $75.0K | $75.0K | $60.0K | |
| Inventories | $4.1M | $2.7M | $2.8M | $2.0M | $1.2M | $1.4M | $1.6M | $1.7M | $1.9M | $844.0K | |
| Finance Income Expense Net | $1.6M | -$10.8M | $8.8M | -$11.2M | -$2.3M | -$436.0K | -$2.4M | ||||
| Services Expense | $8.9M | $11.1M | $10.2M | $9.8M | $9.9M | $11.1M |
Most recent annual filing with the SEC: March 5, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.